Biotechblog – Page 1032 – Biotechnology business, policy, and more!

2010 Biotech Humanitarian Award

I’m honored to have been selected as one of the judges of the 2010 Biotech Humanitarian award. More details are available […]

The January 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to

This is a guest post from Cliff Cramer, Director of the Healthcare and Pharmaceutical Management Program at Columbia Business School.

This is a guest post from BiotechBlog reader Viren Konde. Do you have a response to Viren’s post? If so,

This is my initial response to the Kyoto Prize, which I was able to attend on a fellowship from Point

At a recent event on the comparative advantages of small molecule vs. biologic drugs, several themes emerged which led me

With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that

I am honored to have been selected for the 2009 Kyoto Prize Journalism Fellowship, offered by Point Loma Nazarene University.

The October 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to

In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s